P
ProHub
English 简体中文 繁體中文
Medium Merger & Acquisition Financial Analysis Profitability

Surgical Robot

#Healthcare #Medical Technology
ProHub Comment

This case tests financial analysis and break-even calculations, requiring candidates to evaluate capital investments against their useful life. The key insight is recognizing that while Robot X has a 20-year break-even period (unrealistic given its 10-year lifespan), the superior Da Vinci Robot performs slightly better at 7 years but still leaves minimal profit before replacement. The case effectively demonstrates how absolute numbers can be misleading without contextual analysis.

Estimated Time 26 minutes
Difficulty Medium
Source Cornell
10 / 100
Our client is a privately owned hospital that offers high-tech surgical procedures. They would like to start using robots in their surgeries. Recently, a new surgical robot, Robot X, was developed and has now been on the market for six months. This robot is highly precise and drastically reduces human work in surgeries. Should our client acquire Robot X?

Clarifying Information

  1. Our client specializes in minimally invasive surgeries, but has never employed a full robot
  2. There are currently only a few surgical robots on the market; the Da Vinci Robot is the leader in the market
  3. Of the hospital staff who are authorized to perform surgeries, 70% are technicians (with Bachelor’s degree) and 30% are medical professionals (with M.D.)
  4. Buying a surgical robot will allow our client to hire 5 fewer staff technicians per year
  5. Each staff technician is paid an annual salary of $60,000
  6. The hospital generates an extra $300/surgery that a surgical robot performs
  7. Technology replacement rate is ~10 years for surgical robots
Mock Interview
Interviewer

Our client is a privately owned hospital that offers high-tech surgical procedures. They would like to start using robots in their surgeries. Recently, a new surgical robot, Robot X, was developed and has now been on the market for six months. This robot is highly precise and drastically reduces human work in surgeries. Should our client acquire Robot X?

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

A hospital considering whether to purchase a surgical robot must evaluate the investment through break-even analysis. Robot X requires 20 years to break even (twice its lifespan), while the Da Vinci Robot requires 7 years (slightly less than its lifespan). The recommendation is not to invest in either robot, but to explore alternative service improvements while monitoring competitive threats.

Key Insights:

  1. Break-even analysis is critical for capital investment decisions and must be compared against asset lifespan
  2. Total cost of ownership includes both initial purchase price and annual maintenance costs
  3. Competitive positioning and strategic risk (competitors adopting technology) must be weighed against pure financial metrics
  4. Alternative service improvement options (better equipment, more trained staff, specialization) should be evaluated alongside capital-intensive investments